Health Canada Issues Recall of Apotex`s APO-AMITRIPTYLINE 10mg: NDMA Impurity
Health Canada Issues Recall of AA Pharma`s Amitriptyline antidepressant drugs
AlgoTherapeutix (AlgoTx) has commenced its Phase II clinical trial of ATX01 (topical amitriptyline) for pain relief in chemotherapy-induced peripheral neuropathy (CIPN) in adult patients.
SURESNES, France--(BUSINESS WIRE)--AlgoTx, a biotechnology company dedicated to developing treatments for complex pain, announced today the initiation of its Phase 2 global clinical trial in Chemotherapy-Induced Peripheral Neuropathy in adult patients. The trial will evaluate the efficacy and safety of two concentrations of ATX01 (proprietary topical amitriptyline).
Micro Labs' Generic Chlordiazepoxide & Amitriptyline Receives Approval in U.S.
Enforcement Report - Week of February 28, 2018
The FDA has classified the ongoing recall by drug wholesaler Truxton of 18 lots of phenobarbital and amitriptyline tablets as Class I and Class II recalls.
More than 6 million children and adolescents in the United States have migraines.1-3 The majority continue to have headaches into adulthood, taking a toll on the U.S. economy of approximately $36 billion and resulting in substantial effects on quality of life.4-7 Pediatric clinical practice guidelines for migraine treatment are consensus based rather than evidence based,8,9 with no Food and Drug Administration (FDA)–approved migraine prevention medication for children younger than 12 years of age.
Rusan Pharma Ltd fails EDQM Inspection